-
1.
公开(公告)号:EP4247826A1
公开(公告)日:2023-09-27
申请号:EP21894152.4
申请日:2021-11-17
-
-
公开(公告)号:EP3966220A2
公开(公告)日:2022-03-16
申请号:EP19958750.2
申请日:2019-03-26
申请人: Huang, Zhengmei
发明人: Huang, Zhengmei
IPC分类号: C07H3/04
-
公开(公告)号:EP3846641A1
公开(公告)日:2021-07-14
申请号:EP19761872.1
申请日:2019-09-04
发明人: CAO, Linqiu
IPC分类号: A23L33/21 , A23L33/00 , A61K31/702 , C07H3/04 , C07H3/06
-
公开(公告)号:EP3845233A1
公开(公告)日:2021-07-07
申请号:EP21154787.2
申请日:2017-01-13
申请人: Benebiosis Co., Ltd.
发明人: KANG, Seung Woo
IPC分类号: A61K31/702 , A61K8/60 , A61K8/14 , C07H3/04 , C07H13/02 , A61K9/127 , A61K9/51 , A23L33/10 , A61Q19/08 , A61P25/28 , A61K9/00 , A61K9/107 , A61P3/06 , A61P39/00 , A61P25/16 , A61P9/00 , A61P25/08
摘要: The present invention relates to a composition for preventing or treating diseases or symptoms associated with a reduction in the expression of peroxisome proliferator-activated receptor coactivator 1-alpha (PGC-1α), the composition comprising, as an active ingredient, a compound represented by the following general formula I, a salt thereof, or a solvate thereof.
-
-
-
公开(公告)号:EP3563853A1
公开(公告)日:2019-11-06
申请号:EP17888733.7
申请日:2017-12-27
发明人: GENG, Meiyu , DING, Jian , ZHANG, Zhenqing , XIAO, Zhongping , DU, Xiaoguang , XIN, Xianliang
IPC分类号: A61K31/7016 , A61K31/702 , A61K31/734 , A61P25/28 , A61P9/00 , C08B37/04 , C07H3/04 , C07H3/06 , C07H1/00
摘要: The present invention relates to a mannuronic diacid oligosaccharide composition, comprising a mannuronic diacid of Formula (III) or a pharmaceutically acceptable salt thereof, wherein n is an integer from 1 to 9, m is 0, 1 or 2, and m' is 0 or 1, and wherein the total weight of mannuronic diacids wherein n = 1-5 is 80-95% of the total weight of the composition, and the ratio of the total weight of mannuronic diacids wherein n = 1-3 to the total weight of mannuronic diacids wherein n = 4-7 is between 1.0 and 3.5.
-
公开(公告)号:EP3191598B1
公开(公告)日:2019-06-19
申请号:EP15760467.9
申请日:2015-09-10
-
公开(公告)号:EP3403655A1
公开(公告)日:2018-11-21
申请号:EP17738695.0
申请日:2017-01-13
申请人: Benebiosis Co., Ltd.
发明人: KANG, Seung Woo
IPC分类号: A61K31/7016 , A61K8/60 , A61K8/14 , C07H3/04 , C07H13/02 , A61K9/127 , A61K9/51 , A23L33/10 , A61Q19/08
CPC分类号: A23L33/10 , A61K8/14 , A61K8/60 , A61K9/127 , A61K9/51 , A61K31/7016 , A61Q19/08 , C07H3/04 , C07H13/02
摘要: The present invention relates to a composition for preventing or treating diseases or symptoms associated with a reduction in the expression of peroxisome proliferator-activated receptor coactivator 1-alpha (PGC-1α), the composition comprising, as an active ingredient, a compound represented by the following general formula I, a salt thereof, or a solvate thereof.
-
-
-
-
-
-
-
-
-